Hypertrophic Cardiomyopathy
Conditions
Keywords
Hypertrophic cardiomyopathy, Observatory, LVH
Brief summary
Hypertrophic cardiomyopathy (Hypertrophic CardioMyopathy=HCM) remains a poorly understood disease with an assumption insufficiently codified. There is no data available in France on the profile of patients, diagnostic methods and assessment and therapeutic use. The purpose of this study is to establish a monitoring of patients with HCM (sarcomere of origin or not) in France (diagnosis, treatment)
Detailed description
This both retrospective and prospective study is proposed to cardiology services 50 hospitals in France. A cardiologist referral is designated for each facility. The following data will be collected by the physician during the initial hospitalization * Demographics * Geographic origin of patient * Clinical data: criteria for inclusion and non-inclusion data HCM general, Doppler ultrasound, personal history, family history * Reviews made: non-organic, biological * Family Survey, * Treatments: Medical, Electrical, invasive * Data from hospital The follow-up to 18 months, 3 years and 5 years will be conducted by clinical-research-technicians of the French Society of Cardiology, an application will be made to municipalities of birth and mail a letter to physicians and patients. The following data will be collected: * Vital status * Data from hospital * Reviews made: non-organic, biological * Treatments: Medical, Electrical, invasive
Interventions
None listed
Sponsors
French Cardiology Society
Study design
Observational model
COHORT
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
15 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age ≥ 15 years old * Patient with HCM defined by an ultrasound thickness of the left ventricle ≥ 13 mm if familial or ≥ 15 mm if sporadic
Exclusion criteria
* Expressed refusal to participate in the study * Significant aortic stenosis (\<1 cm ²)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Event-free survival | 3 years |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Diagnostic methods | 0 day | Define the profile of patients with HCM in France, diagnostic methods, evaluation (diagnostic investigation and family) and therapeutic. Who are the patients CMH France? (rules discovery, clinical presentation) and how are assumed the HCM in France? (examinations, hospitalizations, treatments, procedures for the family survey). |
Countries
France
Contacts
Primary ContactAlbert Hagege
Outcome results
None listed